PATH
Menu

A periodic e-newsletter about the introduction of Sayana® Press

Introduction Planning Update will launch in 2014 as a periodic e-newsletter intended to share information with partners, advisors, and stakeholders of PATH’s Sayana® Press Pilot Introduction project. Each issue will contain updates on research, product registration, and introduction planning, and it will also share resources that may be of interest to the project’s global and country stakeholders.

Sign up below to receive the e-newsletter when it becomes available.










Uniject is a trademark of BD. Depo-Provera, depo-subQ provera 104, and Sayana Press are trademarks of Pfizer.

Photo: PATH/Patrick McKern.